Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Free Report) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 54,300 shares, a decline of 17.4% from the January 31st total of 65,700 shares. Currently, 3.9% of the shares of the stock are sold short. Based on an average daily volume of 24,500 shares, the short-interest ratio is presently 2.2 days.
Alaunos Therapeutics Stock Performance
Shares of Alaunos Therapeutics stock opened at $1.51 on Friday. Alaunos Therapeutics has a twelve month low of $1.48 and a twelve month high of $20.30. The business has a 50-day moving average price of $1.72 and a 200 day moving average price of $2.17.
About Alaunos Therapeutics
See Also
- Five stocks we like better than Alaunos Therapeutics
- How to Buy Cheap Stocks Step by Step
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- What is the Euro STOXX 50 Index?
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Alaunos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alaunos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.